Sterile gonadotropin-releasing hormone antagonist formulation for subcutaneous prostate cancer therapy. Distributed by specialty pharmaceutical suppliers to urology clinics and cancer institutes. Sourced by medical procurement for advanced hormone-dependent tumor management.